Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida… - Molecular …, 2022 - nature.com
Antipsychotic drugs are the mainstay in the treatment of schizophrenia. However, one-third
of patients do not show adequate improvement in positive symptoms with non-clozapine …

Deep brain stimulation of the habenula: systematic review of the literature and clinical trial registries

J Germann, M Mameli, GJB Elias, A Loh, A Taha… - Frontiers in …, 2021 - frontiersin.org
The habenula is a small bilateral epithalamic structure that plays a key role in the regulation
of the main monoaminergic systems. It is implicated in many aspects of behavior such as …

Toward personalized medicine in connectomic deep brain stimulation

B Hollunder, N Rajamani, SH Siddiqi, C Finke… - Progress in …, 2022 - Elsevier
At the group-level, deep brain stimulation leads to significant therapeutic benefit in a
multitude of neurological and neuropsychiatric disorders. At the single-patient level …

Deep brain stimulation of the substantia nigra pars reticulata for treatment-resistant schizophrenia: a case report

N Cascella, AA Butala, K Mills… - Biological …, 2021 - biologicalpsychiatryjournal.com
Deep brain stimulation (DBS) is an effective treatment for ParkinsonLs disease (1) via
modulation of motor corticostriatothalamic circuits (CSTs)(2, 3). CST connections to motor …

Power signatures of habenular neuronal signals in patients with bipolar or unipolar depressive disorders correlate with their disease severity

S Sonkusare, Q Ding, Y Zhang, L Wang, H Gong… - Translational …, 2022 - nature.com
The habenula is an epithalamic structure implicated in negative reward mechanisms and
plays a downstream modulatory role in regulation of dopaminergic and serotonergic …

Target selection for deep brain stimulation in treatment resistant schizophrenia

I Corripio, A Roldán, P McKenna, S Sarró… - Progress in Neuro …, 2022 - Elsevier
The use of deep brain stimulation (DBS) in treatment resistant patients with schizophrenia is
of considerable current interest, but where to site the electrodes is challenging. This article …

[HTML][HTML] Implications from translational cross-validation of clinical assessment tools for diagnosis and treatment in psychiatry

K Aryutova, R Paunova, S Kandilarova… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Traditional therapeutic methods in psychiatry, such as psychopharmacology and
psychotherapy help many people suffering from mental disorders, but in the long-term prove …

Circuits regulating pleasure and happiness–focus on potential biomarkers for circuitry including the habenuloid complex

AJM Loonen, SA Ivanova - Acta Neuropsychiatrica, 2022 - cambridge.org
Introduction: The multiplicity and complexity of the neuronal connections in the central
nervous system make it difficult to disentangle circuits that play an essential role in the …

[HTML][HTML] Investigating deep brain stimulation of the habenula: a review of clinical studies

ME Abraham, V Ong, J Gendreau, NJ Brown… - … : Technology at the …, 2023 - Elsevier
Objectives The aim of this study was to examine the current scientific literature on deep brain
stimulation (DBS) targeting the habenula for the treatment of neuropsychiatric disorders …

Transcriptomic analysis of the human habenula in schizophrenia

EA Yalcinbas, B Ajanaku, ED Nelson… - BioRxiv, 2024 - pmc.ncbi.nlm.nih.gov
Pathophysiology of many neuropsychiatric disorders, including schizophrenia (SCZD), is
linked to habenula (Hb) function. While pharmacotherapies and deep brain stimulation …